Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women With Hypothyroidism

Overview

The aim of the study was to evaluate the clinical control program in patients with hypothyroidism during pregnancy (suggested in resent guidelines). Is it possible by monitoring the patients every 4. week during pregnancy to keep the thyroid function parameters within the recommended range? A retrospective study of consecutive pregnant women with hypothyroidism followed at the outpatient clinic at the Endocrinology Unit, Herlev Hospital, Denmark during 2012. Patients selected through electronic medical system. Blood tests for the The hormone levels drawn from the laboratory of Clinical Biochemical Department, Herlev Hospital

Full Title of Study: “Monitoring and Evaluation of the Levothyroxin Replacement Therapy in Pregnant Women”

Study Type

  • Study Type: Observational
  • Study Design
    • Time Perspective: Retrospective
  • Study Primary Completion Date: March 2015

Interventions

  • Other: biomedical outcomes
    • Evaluation of abnormal blodtests (evaluating thyroid function) from predefined control program

Arms, Groups and Cohorts

  • L-T4 treated hypothyroid pregnant women
    • L-T4 treated pregnant women

Clinical Trial Outcome Measures

Primary Measures

  • number of patients with thyroid function parameters within the intended level
    • Time Frame: nine months

Secondary Measures

  • number of complications during pregnancy
    • Time Frame: nine months

Participating in This Clinical Trial

Inclusion Criteria

  • Consecutive pregnant women with L-T4 treated hypothyroidism followed at the outpatient clinic at the Endocrinology Unit, Herlev Hospital, Denmark during 2012

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 45 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Birte Nygaard
  • Provider of Information About this Clinical Study
    • Sponsor-Investigator: Birte Nygaard, Birte Nygaard, md, phd – Herlev Hospital
  • Overall Official(s)
    • Birte Nygaard, MD, phd, Principal Investigator, Endocrine Unit O, Herlev Hospital, University of Copenahgen

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.